Aprocitentan
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Aprocitentan: A New Option for Resistant Hypertension and Its Place in Patient Care.
Journal: Southern medical journal
Published: June 02, 2026
Supramolecular host-guest interactions of TRYVIO and VAFSEO with a benzotriazole nanocapsule: A density functional theory study.
Journal: Journal of molecular graphics & modelling
Published: March 16, 2026
Aprocitentan in resistant hypertension with chronic kidney disease: balancing albuminuria reduction against early volume risk.
Journal: Journal of human hypertension
Published: March 10, 2026
Aprocitentan, an endothelin receptor antagonist for resistant hypertension.
Journal: JAAPA : official journal of the American Academy of Physician Assistants
Published: December 23, 2025
Aprocetentin (Tryvio): A breakthrough in treating Resistant Hypertension.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: December 19, 2025
Revolutionizing resistant hypertension: Unlocking the potential of Aprocitentan.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: December 19, 2025
Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: December 09, 2025
Macitentan vs Standard of Care in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical Trial.
Journal: The Journal of pediatrics
Published: November 18, 2025
Macitentan in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical Trial.
Journal: The Journal of pediatrics
Published: November 18, 2025
Aprocitentan in Resistant Hypertension: Mechanistic Insights, Clinical Evidence, and Future Directions.
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
Published: November 17, 2025
Placental transfer of the novel endothelin-1 receptor antagonist aprocitentan.
Journal: Pregnancy hypertension
Published: October 24, 2025
Clinical Evaluation of QTc Interval Prolongation With the Dual Endothelin Receptor Antagonist Aprocitentan.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: September 12, 2025
Last Updated: 06/30/2026